Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis. 1982

J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford

In 82 white patients with myasthenia gravis, a high serum human acetylcholine receptor (AChR) antibody titer was related to the presence of the HLA-B8 antigen and increasing severity of the disease and not to age at onset, sex, presence of thymoma, or mode of treatment. Among patients without thymomas a high antibody titer was also associated with HLA-B8, particularly in those patients whose age at onset was less than 35 years. Thymectomy was associated with a lower median antibody titer when compared in two groups of HLA-B8-positive patients without thymoma who were similar for all other factors. Patients with thymomas who had received corticosteroids had a lower median titer than those who had not received steroids. This study supports the possibility that immune-response genes near the HLA-B8 segment of the major histocompatibility complex participate in the regulation of the humoral response to autoantigens, such as AChR protein.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
January 1978, Transactions of the American Neurological Association,
J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
November 1978, Tissue antigens,
J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
July 1985, The Journal of thoracic and cardiovascular surgery,
J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
June 1992, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
January 1995, Brain & development,
J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
November 1989, Acta neurologica Scandinavica,
J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
June 1991, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
December 1986, Asian Pacific journal of allergy and immunology,
J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
January 1977, The New England journal of medicine,
J Keesey, and F Naiem, and J Lindstrom, and D Roe, and C Herrmann, and R Walford
January 1993, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!